UE
LLY icon

Unisphere Establishment’s Eli Lilly LLY Stock Holding History

Unisphere Establishment’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.9M Sell
7,500
-2,200
-23% -$2.23M 0.06% 46
2025
Q4 		$10.4M Hold
9,700
– – 0.08% 45
2025
Q3 		$7.4M Hold
9,700
– – 0.06% 52
2025
Q2 		$7.56M Hold
9,700
– – 0.06% 50
2025
Q1 		$8.01M Hold
9,700
– – 0.07% 46
2024
Q4 		$7.49M Buy
9,700
+3,400
+54% +$2.82M 0.07% 49
2024
Q3 		$5.58M Buy
+6,300
New +$5.66M 0.05% 56

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Unisphere Establishment's LLY Position: Q1 2026 in Review

Unisphere Establishment reduced its Eli Lilly (LLY) stake by 23% in Q1 2026, selling an estimated $2.23M and leaving 7,500 shares worth $6.9M. The position accounts for 0.06% of the portfolio, ranked #46.

Unisphere Establishment first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $10.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Unisphere Establishment held 7,500 shares of Eli Lilly worth $6.9M as of Q1 2026.
  • Unisphere Establishment sold 2,200 Eli Lilly shares in Q1 2026, an estimated $2.23M.
  • Eli Lilly made up 0.06% of Unisphere Establishment's portfolio in Q1 2026, its #46 holding.
  • Unisphere Establishment first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Unisphere Establishment's Eli Lilly position peaked at $10.4M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Unisphere Establishment's 13F filing for Q1 2026, filed 14 May 2026.